Ameerex Advances North American Resource Program and Ameerex-Patagonia Lithium JV

July 13, 2026 4:00 PM

Ameerex Corporation, also known as HIRU Corporation (OTCID:HIRU), today provided an update on its North American resource program, including the Corcoran silver-gold project and its Canadian oilfield interests, alongside continued progress on the Ameerex-Patagonia lithium joint venture.North American ProgramAmeerex is advancing two North American projects: the Corcoran silver-gold project and a Canadian oilfield business.These projects will be...

Read more

Desert Oasis Healthcare Uses AI Technology to Help Detect Heart Rhythm Conditions Earlier

July 13, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) is using artificial intelligence (AI) and advanced patient data analysis to help identify people who may be at risk for undiagnosed heart rhythm conditions, known as arrhythmias, before those conditions lead to emergency room visits or hospitalizations.DOHC has implemented Predictive Arrhythmia Solutions™, an exclusive iRhythm Technologies program for healthcare systems that combines candidate identification AI...

Read more

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

July 13, 2026 9:27 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received National Ethics Committee approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company is now getting ready to file a Clinical Trial Application to ACOREP, the regulatory...

Read more

StressPal Study Published in JMIR Formative Research

July 13, 2026 9:10 AM

StressPal, a provider of evidence-based digital resilience interventions for healthcare professionals, today announced the publication of a study evaluating its StressPal Frontline: Essential Resilience Self-Care and Burnout Prevention program in JMIR Formative Research, an open access, peer-reviewed journal focused on emerging digital health innovations.The study, "Resiliency and Stress Among Healthcare Workers: A Quasi-Experimental Pre-Post...

Read more

Gemina Announces Private Placement Offering

July 13, 2026 8:45 AM

Gemina Laboratories Ltd. (the "Company" or "Gemina") is pleased to announce the launch of a private placement of common shares, offered exclusively to existing shareholders of the Company and subject to certain resale restrictions.Financing and Restructuring UpdateOn December 30, 2025, the Company announced its plans to proceed with a non-brokered private placement of secured, non-convertible debentures (the "Debentures") for gross proceeds of a...

Read more

Glioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment

July 13, 2026 8:00 AM

Over the past decade, the Glioblastoma Foundation has worked to advance research, educate patients and caregivers, support the glioblastoma community, and foster collaborations aimed at improving outcomes for individuals facing one of the most aggressive forms of cancer.As it enters its second decade, the Glioblastoma Foundation is expanding its efforts by building the infrastructure needed to advance precision medicine and therapeutic...

Read more

Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating the Next Major Growth Opportunity

July 13, 2026 8:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company developing advanced mushroom production technologies, believes the rapidly expanding state-by-state adoption of psilocybin programs is creating a significant long-term opportunity for scalable manufacturing infrastructure.With Oregon, Colorado, and New Mexico now operating statewide psilocybin programs and more than two dozen states considering medical, research, or decriminalization...

Read more

Invitation to Presentations of Senzime's Second Quarter 2026 Report

July 13, 2026 6:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to presentations of the second quarter report for 2026 on July 16. The report will be published at 08:00 am CEST the same day.Philip Siberg, CEO of Senzime, will present the report through a webcast that can be seen from 09:00 am CEST on Senzime's website senzime.com/investors.A Live Q&A, hosted by Gustaf Meyer, analyst at Redeye, will be aired at 10:00 am CEST via Redeyes...

Read more

Nanografi Increases Click-Through Rates and Scientific Engagement With Bioz

July 13, 2026 4:00 AM

Bioz, the company transforming scientific publications into product credibility, announced its collaboration with Nanografi, a global provider of advanced nanomaterials, graphene products, and laboratory technologies supporting scientific innovation across academia and industry. Through the implementation of Bioz Badges, Nanografi is enhancing how researchers discover and engage with publication-backed validation directly within the digital...

Read more

Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary

July 13, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging leader in the field of longevity research, provides a mid-year operational and corporate summary covering the six-month period to 30 June 2026.No delays in the dog clinical trial: Positive preliminary interim results from the SLAB trial, followed by confirmation of sustained safety and efficacy at the three-month follow-upExpansion of confidentiality...

Read more

Ascelia Pharma Provides Orviglance Update

July 12, 2026 1:00 PM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (STO:ACE), a biopharmaceutical company focused on improving the lives of people living with rare cancer conditions, provides an update following the recent publication of the Complete Response Letter (CRL) by the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Orviglance®.As previously communicated, Ascelia Pharma ("Ascelia") is preparing for a Type A...

Read more

MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings

July 12, 2026 10:15 AM

The most revealing moment of the DEA's marijuana rescheduling process may not have occurred during seven days of testimony in Arlington. It occurred weeks earlier, when the DEA decided who would not be allowed into the hearing room. The agency excluded MMJ International Holdings-the only company developing botanical cannabinoid medicines through the FDA's formal drug approval process-from participating in a hearing whose central question was...

Read more

Marijuana Rescheduling Worth a Billion Dollars in Forgiven Taxes To MSO's Plus More Than Two Billion Annual Tax Savings

July 10, 2026 9:35 PM

On July 2, the Justice Department told the D.C. Circuit that the two parties seeking a stay of the Marijuana Rescheduling Order-a drug-testing association and MMJ International Holdings-"invoke pocketbook interests." The accusation deserves a serious answer, because the government has the ledger pointed in the wrong direction. If the court wants to know who has a financial stake in the outcome of this case, it should look at the parties the...

Read more

Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

July 10, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces the successful completion of its analytical reference standard preparation program for A83B4C63, the active pharmaceutical ingredient ("API") supporting the Company's lead oncology program, ONC010 (the "PNKP Inhibitor Technology").The reference standard program, which was completed in collaboration with Dalton Pharma Services,...

Read more

ADM Tronics Reports Fiscal Year 2026

July 10, 2026 4:52 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies, products, and proprietary medical devices, announces results for fiscal year ended March 31, 2026.During the fiscal year ended March 31, 2026, ADM Tronics continued to advance the development of the human medical version of its proprietary Sonotron® technology. This initiative targets one of healthcare's largest unmet needs-the...

Read more

Revelation Biosciences Announces Adoption of Stockholder Rights Plan

July 10, 2026 4:05 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced that its Board of Directors (the "Board") has adopted a stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right (a "Right") for each outstanding share of the Company's common stock.The Rights Plan was adopted...

Read more

SPIN Magazine Features Ten Celebrities and Their Ayahuasca Journeys at Rythmia

July 10, 2026 1:30 PM

A new feature in SPIN Magazine profiles ten celebrities who traveled to Rythmia Life Advancement Center for ayahuasca, and details how the experience reshaped their lives.The story arrives as psychedelic healing continues its move into the mainstream, showing up across television, film, and music, and in candid testimonials from public figures willing to talk on the record.Among the ten featured are Southern Charm's Shep Rose, who wrote a memoir...

Read more

Nursing Home Abuse Center Launches Free Nursing Home Neglect Screening Tool for Families

July 10, 2026 12:44 PM

The Nursing Home Abuse Center has launched its free, 3-minute, 5-question screening tool for anyone concerned about nursing home neglect. This rapid online assessment helps families recognize potential signs of neglect. It's available on the organization's website and requires no registration or personal information to access.Nursing home neglect remains one of the most underreported and misunderstood problems in long-term care. Families who...

Read more

Qure.ai Strengthens North America Leadership Team to Accelerate U.S. Expansion

July 10, 2026 12:43 PM

Qure.ai today announced the promotion of Amy Casey, a former Microsoft and Nuance leader, to Executive Vice President of Sales for North America and the appointment of Malika Shrivastava, a former Google executive, as its first Chief Marketing Officer, strengthening its leadership team as the company scales its commercial operations to meet growing demand for healthcare AI in the United States.Qure.ai expands its North American commercial...

Read more

Hopelessness Is Rising Around the World. Science Says We Can Solve It, and on July 12, We Begin

July 10, 2026 12:35 PM

Somewhere today, a teenager will stop believing tomorrow can be better. She is not alone: more than half of US teen girls report persistent sadness or hopelessness, and hopelessness predicts loneliness, anxiety, depression, violence, self-harm, and suicide. But new peer-reviewed research delivers stunning news: Hope is not a personality trait or a lucky break. It is a skill, it is teachable, and this is a crisis we can solve.That is why iFred,...

Read more